Sitagliptin phosphate monohydrate / simvastatin

Key facts

Active substance
  • sitagliptin phosphate monohydrate
  • simvastatin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/171/2009
PIP number
Sitagliptin phosphate monohydrate / simvastatin
Pharmaceutical form(s)
Film-coated tablet
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
Belgium
E-mail: pip.information@merck.com
Tel. +31 412663179
Fax +31 412662571
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating